Peptide Drug Discovery and Development (PDF)

CHALLENGES AND STRATEGIES IN TRANSLATIONAL RESEARCH WITH PEPTIDE DRUGS Peptides as leads for drug discovery Marketing antimicrobial peptides: a critical academic point of view Oral peptide drug delivery: Strategies to overcome challenges Rational design of amphipathic alpha-helical and cyclic beta-sheet antimicrobial peptides: specificity and therapeutic potential Conotoxin-based leads in drug design Plant antimicrobial peptides: from basic structures to applied research PEPTIDE DRUGS BEFORE, THROUGH AND AFTER INDUSTRY PIPELINES Omiganan pentahydrochloride: a novel, broad-spectrum antimicrobial peptide for topical use Turning endogenous peptides into new analgesics: the example of kyotorphin derivatives The development of romiplostim ? a therapeutic peptibody used to stimulate platelet production HIV vs. HIV: turning HIV-derived peptides into drugs Sifuvirtide, a novel HIV-1 fusion inhibitor WHITHER PEPTIDE DRUGS? - PEPTIDES SHAPING THE FUTURE OF DRUG DEVELOPMENT Endogenous peptides and their receptors as drug discovery targets to treat metabolic disease Motilin and ghrelin receptor agonists as drugs for gastrointestinal disorders Of mice and men: Translational research on amylin agonism Peptides and polypeptides as immunomodulators and their consequential therapeutic effect in multiple sclerosis and other autoimmune diseases Development of antibody fragments for therapeutic applications

Miguel Castanho is head of the Biochemistry department of the School of Medicine at the University of Lisbon (Portugal). He also leads the Physical Biochemistry research unit at the Institute of Molecular Medicine. His main field of research is the interaction of peptide drugs with lipids, in particular the role of lipid membranes in the mechanism of action of peptide drugs.

Nuno C. Santos is the leader of the Biomembranes Unit of the Institute of Molecular Medicine. His research is centered on the specific functions of biological membranes lipids and proteins, with a special focus on their relevance for pathologic processes ranging from viral or bacterial infection to cardiovascular diseases.

Together, Miguel Castanho and Nuno C. Santos have been involved in many collaborative drug discovery and development projects with industry partners in Europe, USA, Canada, and China.

Dieses eBook können Sie uneingeschränkt auf allen Geräten der tolino Familie lesen. Zum Lesen auf sonstigen eReadern und am PC benötigen Sie eine Adobe ID.